FLAMINIM

Main information

  • Trade name:
  • FLAMINIM 1 INJ
  • Dosage:
  • 500,500;MG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 1
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLAMINIM 1 INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

26-2-2018

FDA Drug Safety Communication: FDA approves label changes for antibacterial Doribax (doripenem) describing increased risk of death for ventilator patients with pneumonia

FDA Drug Safety Communication: FDA approves label changes for antibacterial Doribax (doripenem) describing increased risk of death for ventilator patients with pneumonia

[03-06-2014] The U.S. Food and Drug Administration (FDA) has concluded that Doribax (doripenem), an antibacterial drug that has been used to treat patients who develop pneumonia while on ventilators, carries an increased risk of death and lower clinical cure rates compared to use of imipenem and cilastatin for injection (marketed in the U.S. under the name Primaxin).

FDA - U.S. Food and Drug Administration

7-2-2018

IMIPENEM AND CILASTATIN Injection, Powder, For Solution [Hospira, Inc.]

IMIPENEM AND CILASTATIN Injection, Powder, For Solution [Hospira, Inc.]

Updated Date: Feb 7, 2018 EST

US - DailyMed

5-1-2018

IMIPENEM Powder [Merck Sharp Dohme Corp.]

IMIPENEM Powder [Merck Sharp Dohme Corp.]

Updated Date: Jan 5, 2018 EST

US - DailyMed